Login to Your Account

Pharma: Clinic Roundup

Friday, April 20, 2012
• Eisai Inc., of Woodcliff Lake, N.J., said results from a Phase III study of adjunctive perampanel for refractory partial-onset seizures were published in Neurology.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription